Different radiation fields after breast cancer surgery
Part of Cancer, Injuries & trauma, Skin clinical trials.
This trial compares two ways of giving radiation to lymph node areas near the collarbone after surgery for invasive breast cancer. It aims to see which radiation approach works better and is safer for preventing cancer returning in these lymph nodes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have invasive breast cancer and were newly diagnosed
- You can take part in the study for the next 3–5 years and can attend follow-up visits
- You are able to do daily activities fairly well (ECOG 0–1)
- You had breast-conserving surgery or mastectomy, and the underarm lymph nodes (levels I and II) were removed/cleared with at least 10 lymph nodes checked
- You received at least 6 cycles of standard chemotherapy, and (if HER2-positive) you can receive HER2-target treatment
- You do not have distant spread (metastasis), and your cancer is not an N3c type (supraclavicular node metastasis at diagnosis)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether adding targeted radiation to lymph nodes after breast surgery can lower the chance of breast cancer coming back in people with higher-risk, node-negative disease. If you qualify, you may get a planned radiation approach designed for prevention, not treatment of spread.
This trial tests giving a focused, higher dose of radiation to the lymph nodes above the collarbone after breast cancer treatment. It is for patients whose cancer did not fully disappear from those nodes after pre-surgery chemotherapy, to see if extra radiation can help prevent recurrence.
This Phase 3 trial tests whether a shorter, more focused radiation treatment to the regional lymph nodes works as well as the current standard approach for certain breast cancers. It may help patients by potentially improving treatment efficiency while keeping cancer control effective.
This study compares two radiation schedules for breast cancer patients at high risk of cancer returning in lymph nodes. Both use modern radiation therapy, but one delivers treatment faster (ultra-hypofractionated) while the other uses a more moderate schedule. The goal is to see which approach works better with fewer side effects.
This trial is testing whether giving radiation to nearby lymph nodes after surgery can help prevent breast cancer from coming back. It is for women with a specific type of breast cancer that has spread to a few lymph nodes but can be removed with surgery.
This trial compares two ways to treat the underarm lymph nodes in people whose sentinel lymph node still shows limited cancer after chemotherapy and hormone treatment. It may help find which approach controls cancer better with fewer side effects.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.